Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

56°
- Middle Point, OH (45863)
  Today
  
  Partly cloudy this morning, then becoming cloudy during the afternoon. Warm. High 72F. Winds WSW at 15 to 25 mph..
  
  Tonight
  
  Cloudy. Low 38F. Winds N at 10 to 15 mph.
  
  Updated: March 20, 2026 @ 9:45 am
- Full Forecast

Site search

Home
News
- Local News
Sports
Obituaries
Local Events
Photos
e-Edition
Classifieds

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Relmada Therapeutics, Inc. - Common Stock (NQ:RLMD)

6.338 +0.088 (+1.40%)

Streaming Delayed Price Updated: 10:34 AM EDT, Mar 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Relmada Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Earnings Outlook For Relmada Therapeutics ↗

March 18, 2024

Via Benzinga

Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Buying ↗

February 01, 2024

The Dow Jones index closed lower by more than 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...

Via Benzinga

Topics Stocks

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 04, 2024

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 04, 2024

Via Benzinga

Earnings Outlook For Relmada Therapeutics ↗

November 07, 2023

Via Benzinga

Relmada Therapeutics: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Earnings Preview For Relmada Therapeutics ↗

May 10, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 04, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 21, 2023

Via Benzinga

Relmada Therapeutics' Lead Candidate Shows Promise In Pivotal Depression Study ↗

September 20, 2023

Relmada Therapeutics Inc (NASDAQ: RLMD) announced efficacy results for the de novo (or new to treatment) patients (204 patients) and safety results for all subjects (627 patients) from the Phase 3...

Via Benzinga

Bragar Eagel & Squire, P.C. Is Investigating Shift4, Waldencast, Relmada, and DoubleVerify and Encourages Investors to Contact the Firm

August 11, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

FDA's Rejection of Sage/Biogen's Zuranolone Boosts Prospects for Axsome's Auvelity, Analyst Says ↗

August 07, 2023

Axsome Therapeutics Inc (NASDAQ: AXSM) reported Q2 sales of $46.7 million, beating the consensus of $40.19 million.

Via Benzinga

Bragar Eagel & Squire, P.C. Is Investigating Shift4, Waldencast, Relmada, and DoubleVerify and Encourages Investors to Contact the Firm

August 06, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick ↗

July 31, 2023

For investors who choose wisely, profits in healthcare stocks can be spectacular. But the losses can also be dramatic if you choose poorly.

Via InvestorPlace

Bragar Eagel & Squire, P.C. Is Investigating Relmada, Arrival, FMC, and Viasat and Encourages Investors to Contact the Firm

July 26, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Relmada, DoubleVerify, and Castle and Encourages Investors to Contact the Firm

July 21, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Shift4, Waldencast, Relmada, and DoubleVerify and Encourages Investors to Contact the Firm

July 16, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Shift4, Waldencast, Chegg, and Relmada and Encourages Investors to Contact the Firm

July 10, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Shift4, Waldencast, Chegg, and Relmada and Encourages Investors to Contact the Firm

July 05, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Seagate, Chegg, Relmada, and DoubleVerify and Encourages Investors to Contact the Firm

July 01, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Relmada, DoubleVerify, Sanmina, and JinkoSolar and Encourages Investors to Contact the Firm

June 25, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Seagate, Chegg, and Relmada and Encourages Investors to Contact the Firm

June 19, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

RLMD INVESTOR NEWS: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Relmada Therapeutics, Inc. Investors With Losses to Inquire About Securities Class Action Investigation – RLMD

June 10, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Relmada, Bowlero, and Integra and Encourages Investors to Contact the Firm

June 04, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Relmada, and Sanmina and Encourages Investors to Contact the Firm

May 19, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Fox, Cutera, and Relmada and Encourages Investors to Contact the Firm

May 14, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Investor Alert: Investigation Concerning Potential Securities Laws Violations ↗

May 11, 2023

San Diego, CA -- (SBWIRE) -- 05/11/2023 -- An investigation was announced for investors of Relmada Therapeutics, Inc. (NASDAQ:RLMD) shares over potential securities laws violations by Relmada...

Via SBWire

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Relmada Therapeutics, Inc. (RLMD) Investigation

May 11, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Earnings Scheduled For May 11, 2023 ↗

May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...

Via Benzinga

RELMADA ALERT: Bragar Eagel & Squire, P.C. is Investigating Relmada Therapeutics, Inc. on Behalf of Relmada Stockholders and Encourages Investors to Contact the Firm

May 09, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Announcements
Sports
Entertainment
Local Events
Obituaries
Photos
Videos
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

minstercommunitypost.com
PO Box 155
Minster, OH 45863
Phone: 419-300-1076
Email: editor@minstercommunitypost.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Middle Point, OH (45863)

Today

Tonight

Relmada Therapeutics, Inc. - Common Stock (NQ:RLMD)

All News about Relmada Therapeutics, Inc. - Common Stock

Sections

Services